Type of hematological malignancy was determined using ICD-10 codes and was first classified in 11 categories: acute myeloid leukemia (AML), acute lymphoid leukemia (ALL), unknown type of acute leukemia, chronic lymphoid leukemia (CLL), multiple myeloma (MM), non-Hodgkin’s lymphoma (NHL), Hodg...
We identified patients with acute leukemia (myeloid and lymphoid) and PEM using appropriate ICD-10 diagnostic codes. We stratified patients with acute leukemia based on the presence or absence of PEM. A survey multivariable logistic and linear regression analysis was used to calculate adjusted odds ...
Leukemia and Lymphoma 34(5-6): 443–449. Bukowski JA, Huebner WW, Schnatter AR, Wojcik NC (2003) An analysis of the risk of B-lymphocyte malignancies in industrial cohorts. J Toxicol Environ Hlth 66(7): 581–597. Capleton AC, Levy LS (2005) An overview of occupational benzene ...
Leukocyte immunoglobulin-like receptor B (LILRB), a family of immune checkpoint receptors, contributes to acute myeloid leukemia (AML) development, but the specific mechanisms triggered by activation or inhibition of these immune checkpoints in cancer is
ICD-9-CM: International classification of diseases, clinical modification, 9th revision COPD: Chronic obstructive pulmonary disease CHD: Coronary heart disease CKD: Chronic kidney disease RBC: Red blood cell WBC: White blood cells BE: Base excess RDW: Red blood cell distribution width ...
A case of acute coronary syndrome manifesting as an adverse effect of all-trans retinoic acid in a lady with acute promyelocytic leukemia who had no other risk factors for cardiovascular disease [1A]. From: Side Effects of Drugs Annual, 2016 ...
Empty CellHR (95% CI)β Coefficient Valuep ValueScore Points GLS >−15% 6.91 (3.27–14.59) 1.93 <0.001 6 Pre-existing CV disease 3.74 (1.82–7.67) 1.32 <0.001 4 Leukemia type (AML) 4.10 (1.90–8.85) 1.41 <0.001 4 EF <50% 3.50 (1.64–7.51) 1.25 <0.001 4 Age >60 yrs 1.36 (...
In particular, the treatment of AML cells with daunorubicin (DNR), but not cytarabine (Ara-C), results in the maturation of dendritic cells (DCs) and in the efficient cross-priming of anti-leukemia T cells [1,3,4,5,6,7]. This process, immunogenic cell death (ICD), is characterized ...
Keywords: acute myeloid leukemia; tumor immunological microenvironment; immunotherapy; immune checkpoint blockade; bispecific antibodies 1. Introduction Acute myeloid leukemia (AML) is characterized by bone marrow (BM) and tissue infiltration with proliferative, clonal, abnormally differentiated cells of ...
Eur J Cancer B Oral Oncol. 1996;32B:114-1198736173Google ScholarCrossref 11. Sigounas G, Anagnostou A, Steiner M. dl-alpha-Tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer. 1997;28:30-359200147Google ScholarCrossref 12. Meydani SN, Beharka AA...